Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| INSR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 6.35E4 | Evidence |
|
||||
| INSR | CRKL | CRKL: Crk-like protein | 6.35E4 | Evidence |
|
||||
| INSR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 6.35E4 | Evidence |
|
||||
| INSR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 5.39E4 | Evidence | |||||
| INSR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 3.97E4 | Evidence |
|
||||
| INSR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 1.63E4 | Evidence |
|
||||
| INSR | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.74E3 | Evidence |
|
||||
| INSR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
| INSR | STAT3 | 200.0 | Evidence | ||||||
| INSR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
| INSR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 147.0 | Evidence | |||||
| INSR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
| INSR | GRB10 | N/A | 141.0 | Evidence |
|
||||
| INSR | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 135.0 | Evidence |
|
||||
| INSR | SYK | SYK: Tyrosine-protein kinase SYK | 132.0 | Evidence | |||||
| INSR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 132.0 | Evidence | |||||
| INSR | LYN | LYN: Tyrosine-protein kinase Lyn | 132.0 | Evidence | |||||
| INSR | BMX | N/A | 125.0 | Evidence | |||||
| INSR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
| INSR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 101.0 | Evidence |
|
||||
| INSR | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 101.0 | Evidence |
|
||||
| INSR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.30 | Evidence | |||||
| INSR | CRK | CRK: Proto-oncogene C-crk | 85.60 | Evidence |
|
||||
| INSR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 80.50 | Evidence | |||||
| INSR | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 80.00 | Evidence | |||||
| INSR | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 80.00 | Evidence | |||||
| INSR | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 80.00 | Evidence | |||||
| INSR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 80.00 | Evidence | |||||
| INSR | APS | SH2B2, APS: SH2B adapter protein 2 | 80.00 | Evidence |
|
||||
| INSR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence |
|
||||
| INSR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 72.70 | Evidence |
|
||||
| INSR | VAV1 | VAV1, VAV: Proto-oncogene vav | 72.10 | Evidence |
|
||||
| INSR | JAK1 | 72.10 | Evidence |
|
|||||
| INSR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 72.10 | Evidence | |||||
| INSR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 62.10 | Evidence | |||||
| INSR | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 55.80 | Evidence | |||||
| INSR | GRAP | GRAP: GRB2-related adapter protein | 53.20 | Evidence | |||||
| INSR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 53.20 | Evidence | |||||
| INSR | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 52.50 | Evidence | |||||
| INSR | RIN1 | RIN1: Ras and Rab interactor 1 | 52.50 | Evidence | |||||
| INSR | HCK | N/A | 52.50 | Evidence | |||||
| INSR | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 49.00 | Evidence | |||||
| INSR | CSK | CSK: Tyrosine-protein kinase CSK | 47.30 | Evidence |
|
||||
| INSR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.10 | Evidence | |||||
| INSR | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 43.60 | Evidence | |||||
| INSR | EHD4 | EHD4, HCA10, FKSG7, HCA11, PAST4: EH domain-containing protein 4 | 40.60 | Evidence | |||||
| INSR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 39.10 | Evidence | |||||
| INSR | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
| INSR | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 33.90 | Evidence | |||||
| INSR | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
| INSR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 31.20 | Evidence | |||||
| INSR | GNAO1 | GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 | 31.10 | Evidence | |||||
| INSR | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 29.30 | Evidence |
|
||||
| INSR | GHR | GHR: Growth hormone receptor precursor | 28.20 | Evidence | |||||
| INSR | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 28.20 | Evidence | |||||
| INSR | EPOR | EPOR: Erythropoietin receptor precursor | 28.20 | Evidence | |||||
| INSR | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 28.20 | Evidence | |||||
| INSR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 25.3 | Evidence | |||||
| INSR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 25.3 | Evidence |
|
||||
| INSR | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 24.80 | Evidence | |||||
| INSR | GNAT1 | GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit | 23.20 | Evidence | |||||
| INSR | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 22.90 | Evidence | |||||
| INSR | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 22.90 | Evidence | |||||
| INSR | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 22.90 | Evidence |
|
||||
| INSR | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 22.90 | Evidence | |||||
| INSR | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 22.30 | Evidence | |||||
| INSR | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 22.20 | Evidence |
|
||||
| INSR | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 22.20 | Evidence | |||||
| INSR | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
| INSR | DAB2 | DAB2, DOC2: Disabled homolog 2 | 21.60 | Evidence | |||||
| INSR | PRLR | PRLR: Prolactin receptor precursor | 21.10 | Evidence | |||||
| INSR | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 20.50 | Evidence |
|
||||
| INSR | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 20.50 | Evidence | |||||
| INSR | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 20.40 | Evidence | |||||
| INSR | GNAZ | GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha | 20.40 | Evidence | |||||
| INSR | GNAT2 | GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit | 20.40 | Evidence | |||||
| INSR | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 20.00 | Evidence | |||||
| INSR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
| INSR | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 19.70 | Evidence | |||||
| INSR | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 19.10 | Evidence | |||||
| INSR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 18.90 | Evidence | |||||
| INSR | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 18.60 | Evidence | |||||
| INSR | S100A3 | S100A3, S100E: Protein S100-A3 | 18.60 | Evidence | |||||
| INSR | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 17.60 | Evidence | |||||
| INSR | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 17.10 | Evidence | |||||
| INSR | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 17.10 | Evidence | |||||
| INSR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 16.60 | Evidence | |||||
| INSR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 16.40 | Evidence | |||||
| INSR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 15.50 | Evidence | |||||
| INSR | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 15.30 | Evidence | |||||
| INSR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 15.30 | Evidence | |||||
| INSR | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 15.10 | Evidence | |||||
| INSR | SELE | SELE, ELAM1: E-selectin precursor | 15.00 | Evidence | |||||
| INSR | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 15.00 | Evidence | |||||
| INSR | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 15.00 | Evidence | |||||
| INSR | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 15.00 | Evidence | |||||
| INSR | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 14.60 | Evidence | |||||
| INSR | IRS2 | IRS2: Insulin receptor substrate 2 | 13.90 | Evidence |
|
||||
| INSR | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.60 | Evidence | |||||
| INSR | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.50 | Evidence | |||||
| INSR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 13.50 | Evidence | |||||
| INSR | ACTN4 | ACTN4: Alpha-actinin-4 | 13.50 | Evidence | |||||
| INSR | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 13.50 | Evidence | |||||
| INSR | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 13.50 | Evidence | |||||
| INSR | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 13.50 | Evidence | |||||
| INSR | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 13.50 | Evidence | |||||
| INSR | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 13.40 | Evidence | |||||
| INSR | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 13.20 | Evidence | |||||
| INSR | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 12.10 | Evidence | |||||
| INSR | EVL | EVL, RNB6: Ena/VASP-like protein | 11.70 | Evidence | |||||
| INSR | NULL | Ig lambda chain V-II region NEI | 11.70 | Evidence | |||||
| INSR | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 11.60 | Evidence | |||||
| INSR | CGA | CGA: Glycoprotein hormones alpha chain precursor | 11.40 | Evidence | |||||
| INSR | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 11.30 | Evidence | |||||
| INSR | CCR5 | CCR5: CCR5 receptor (Fragment) | 11.30 | Evidence | |||||
| INSR | IRS1 | IRS1: Insulin receptor substrate 1 | 11.20 | Evidence |
|
||||
| INSR | GAB1 | GAB1: GRB2-associated-binding protein 1 | 11.20 | Evidence |
|
||||
| INSR | ASGR1 | ASGR1: Asialoglycoprotein receptor 1 | 11.20 | Evidence | |||||
| INSR | SHC2 | N/A | 10.70 | Evidence | |||||
| INSR | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 10.50 | Evidence | |||||
| INSR | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 10.10 | Evidence | |||||
| INSR | DAB1 | DAB1: Disabled homolog 1 | 10.10 | Evidence | |||||
| INSR | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 9.94 | Evidence | |||||
| INSR | S100B | S100B: Protein S100-B | 9.94 | Evidence | |||||
| INSR | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 9.92 | Evidence | |||||
| INSR | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 8.90 | Evidence |
|
||||
| INSR | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 8.90 | Evidence | |||||
| INSR | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 8.90 | Evidence | |||||
| INSR | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 8.90 | Evidence | |||||
| INSR | CDC25C | CDC25C: M-phase inducer phosphatase 3 | 8.89 | Evidence | |||||
| INSR | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 8.78 | Evidence | |||||
| INSR | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 8.63 | Evidence | |||||
| INSR | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 8.55 | Evidence | |||||
| INSR | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 8.03 | Evidence | |||||
| INSR | DOK1 | DOK1: Docking protein 1 | 8.03 | Evidence |
|
||||
| INSR | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 8.03 | Evidence | |||||
| INSR | GNA11 | GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 | 7.78 | Evidence | |||||
| INSR | THBS3 | THBS3, TSP3: Thrombospondin-3 precursor | 7.66 | Evidence | |||||
| INSR | LOC649805 | Ig heavy chain V-II region COR | 7.14 | Evidence | |||||
| INSR | MARK2 | N/A | 7.14 | Evidence | |||||
| INSR | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 7.12 | Evidence | |||||
| INSR | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 6.63 | Evidence |
|
||||
| INSR | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 6.52 | Evidence | |||||
| INSR | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 6.52 | Evidence | |||||
| INSR | VIL1 | VIL1, VIL: Villin-1 | 6.12 | Evidence | |||||
| INSR | PRKD3 | PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 | 5.89 | Evidence | |||||
| INSR | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 5.84 | Evidence | |||||
| INSR | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 5.84 | Evidence | |||||
| INSR | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 5.84 | Evidence | |||||
| INSR | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 5.27 | Evidence | |||||
| INSR | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 5.27 | Evidence | |||||
| INSR | STK38L | STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like | 5.27 | Evidence | |||||
| INSR | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 5.27 | Evidence | |||||
| INSR | SOS1 | SOS1: Son of sevenless homolog 1 | 5.07 | Evidence | |||||
| INSR | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 4.96 | Evidence | |||||
| INSR | GMFB | GMFB: Glia maturation factor beta | 4.86 | Evidence | |||||
| INSR | ASB6 | ASB6: Ankyrin repeat and SOCS box protein 6 | 4.80 | Evidence | |||||
| INSR | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 4.80 | Evidence | |||||
| INSR | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 4.80 | Evidence | |||||
| INSR | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 4.80 | Evidence | |||||
| INSR | SRA1 | APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 | 4.80 | Evidence | |||||
| INSR | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 4.56 | Evidence | |||||
| INSR | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 4.48 | Evidence | |||||
| INSR | YWHAG | YWHAG: 14-3-3 protein gamma | 4.48 | Evidence | |||||
| INSR | TSHR | N/A | 4.27 | Evidence | |||||
| INSR | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 4.18 | Evidence | |||||
| INSR | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 4.02 | Evidence | |||||
| INSR | IL10RB | IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor | 4.01 | Evidence | |||||
| INSR | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 4.01 | Evidence | |||||
| INSR | STYK1 | STYK1, NOK: Tyrosine protein-kinase STYK1 | 4.01 | Evidence | |||||
| INSR | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 4.01 | Evidence | |||||
| INSR | TSC2 | TSC2, TSC4: Tuberin | 4.01 | Evidence | |||||
| INSR | KCNJ3 | KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 | 3.79 | Evidence | |||||
| INSR | HLA-DQA1 | HLA-DQA2, HLA-DXA: HLA class II histocompatibility antigen, DQ(6) alpha chain pr | 3.70 | Evidence | |||||
| INSR | SCN4B | SCN4B: Sodium channel beta-4 subunit precursor | 3.70 | Evidence | |||||
| INSR | CRLF2 | CRLF2, ILXR, TSLPR: Cytokine receptor-like factor 2 precursor | 3.70 | Evidence | |||||
| INSR | MICAL-L1 | MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 | 3.69 | Evidence | |||||
| INSR | TUBB2A | TUBB2A, TUBB2: Tubulin beta-2A chain | 3.69 | Evidence | |||||
| INSR | WASPIP | N/A | 3.62 | Evidence | |||||
| INSR | IL2RG | IL2RG: Cytokine receptor common gamma chain precursor | 3.62 | Evidence | |||||
| INSR | MAL2 | MAL2: Protein MAL2 | 3.58 | Evidence | |||||
| INSR | ETS2 | ETS2: Protein C-ets-2 | 3.49 | Evidence | |||||
| INSR | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 3.46 | Evidence | |||||
| INSR | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 3.4 | Evidence | |||||
| INSR | STAP2 | Uncharacterized protein ENSP00000317912 | 3.28 | Evidence | |||||
| INSR | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 3.28 | Evidence | |||||
| INSR | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 3.27 | Evidence | |||||
| INSR | NCF2 | NCF2: Neutrophil cytosol factor 2 | 3.15 | Evidence | |||||
| INSR | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 2.95 | Evidence | |||||
| INSR | BCR | N/A | 2.93 | Evidence | |||||
| INSR | OSTF1 | N/A | 2.84 | Evidence | |||||
| INSR | KRT18 | KRT18: Uncharacterized protein KRT18 | 2.83 | Evidence | |||||
| INSR | RASA4 | RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 | 2.83 | Evidence | |||||
| INSR | LRFN3 | LRFN3, UNQ5865/PRO34192: Leucine-rich repeat and fibronectin type-III domain-con | 2.76 | Evidence | |||||
| INSR | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 2.43 | Evidence | |||||
| INSR | PDCD1 | PDCD1, PD1: Programmed cell death protein 1 precursor | 2.43 | Evidence | |||||
| INSR | DLG1 | N/A | 2.32 | Evidence | |||||
| INSR | TRHR | TRHR: Thyrotropin-releasing hormone receptor | 2.28 | Evidence | |||||
| INSR | CRK | N/A | 2.19 | Evidence |
|
||||
| INSR | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 2.18 | Evidence | |||||
| INSR | H1FX | H1FX: Histone H1x | 2.12 | Evidence | |||||
| INSR | EVL | N/A | 1.96 | Evidence | |||||
| INSR | RP2 | RP2: Protein XRP2 | 1.93 | Evidence | |||||
| INSR | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 1.93 | Evidence | |||||
| INSR | USP47 | USP47: Ubiquitin carboxyl-terminal hydrolase 47 | 1.93 | Evidence | |||||
| INSR | USP10 | USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 | 1.93 | Evidence | |||||
| INSR | ANXA6 | ANXA6, ANX6: Annexin A6 | 1.91 | Evidence | |||||
| INSR | SOS2 | SOS2: Son of sevenless homolog 2 | 1.81 | Evidence | |||||
| INSR | ZA20D1 | OTUD7B, ZA20D1: OTU domain-containing protein 7B | 1.79 | Evidence | |||||
| INSR | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 1.78 | Evidence | |||||
| INSR | PTPN11 | N/A | 1.74 | Evidence |
|
||||
| INSR | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 1.74 | Evidence | |||||
| INSR | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 1.74 | Evidence | |||||
| INSR | PTPNS1 | N/A | 1.67 | Evidence | |||||
| INSR | CDKN1B | CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B | 1.63 | Evidence | |||||
| INSR | PGAM1 | PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 | 1.63 | Evidence | |||||
| INSR | CDC2 | CDC2: Cell division control protein 2 homolog | 1.53 | Evidence | |||||
| INSR | CAMKK1 | N/A | 1.53 | Evidence | |||||
| INSR | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 1.5 | Evidence | |||||
| INSR | BID | BID: BH3-interacting domain death agonist | 1.42 | Evidence | |||||
| INSR | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 1.32 | Evidence | |||||
| INSR | COPA | COPA: Coatomer subunit alpha | 1.32 | Evidence | |||||
| INSR | MYO3A | MYO3A: Myosin IIIA | 1.32 | Evidence | |||||
| INSR | VCP | VCP: Transitional endoplasmic reticulum ATPase | 1.32 | Evidence | |||||
| INSR | TPH1 | N/A | 1.31 | Evidence | |||||
| INSR | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 1.30 | Evidence | |||||
| INSR | ABCF1 | N/A | 1.30 | Evidence | |||||
| INSR | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 1.30 | Evidence | |||||
| INSR | VCPIP1 | VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 | 1.30 | Evidence | |||||
| INSR | CHUK | N/A | 1.30 | Evidence | |||||
| INSR | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 1.30 | Evidence | |||||
| INSR | STIP1 | STIP1: Stress-induced-phosphoprotein 1 | 1.30 | Evidence | |||||
| INSR | MATK | 1.30 | Evidence | ||||||
| INSR | CDC2L1 | CDC2L1, PITSLREA, PK58: PITSLRE serine/threonine-protein kinase CDC2L1 | 1.30 | Evidence | |||||
| INSR | GNA14 | GNA14: Guanine nucleotide-binding protein alpha-14 subunit | 1.19 | Evidence | |||||
| INSR | ITPKA | ITPKA: Inositol-trisphosphate 3-kinase A | 1.17 | Evidence | |||||
| INSR | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 1.17 | Evidence | |||||
| INSR | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 1.17 | Evidence |
|
||||
| INSR | DYRK3 | N/A | 1.17 | Evidence | |||||
| INSR | RARS | RARS: Arginyl-tRNA synthetase, cytoplasmic | 1.17 | Evidence | |||||
| INSR | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 1.17 | Evidence | |||||
| INSR | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 1.16 | Evidence | |||||
| INSR | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 1.16 | Evidence | |||||
| INSR | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 1.15 | Evidence | |||||
| INSR | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 1.14 | Evidence | |||||
| INSR | CDK2 | CDK2: Cell division protein kinase 2 | 1.14 | Evidence | |||||
| INSR | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 1.1 | Evidence | |||||
| INSR | PIK3R1 | N/A | 1.07 | Evidence |
|
||||
| INSR | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 1.05 | Evidence | |||||
| INSR | DPF2 | DPF2, REQ, UBID4: Zinc finger protein ubi-d4 | 1.05 | Evidence | |||||
| INSR | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 1.05 | Evidence | |||||
| INSR | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 1.05 | Evidence | |||||
| INSR | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.05 | Evidence |
|
||||
| INSR | NRAS | NRAS, HRAS1: GTPase NRas precursor | 1.05 | Evidence | |||||